Corporate calendar for Caribou Biosciences, Inc. (CRBU): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address both hematologic malignancies (blood cancers) and solid tumors, serving patients across the United States and internationally.
Price
| Price | $1.25 |
| Market Cap | $124M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AARD · ALLO · ENTA · FHTX · HUMA · IVA · OBIO
Explore sector: Healthcare · Biotechnology
More sections of CRBU: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks